DK1962817T3 - Transdermal tilførsel af et salt af meptazinol - Google Patents
Transdermal tilførsel af et salt af meptazinolInfo
- Publication number
- DK1962817T3 DK1962817T3 DK06848981.4T DK06848981T DK1962817T3 DK 1962817 T3 DK1962817 T3 DK 1962817T3 DK 06848981 T DK06848981 T DK 06848981T DK 1962817 T3 DK1962817 T3 DK 1962817T3
- Authority
- DK
- Denmark
- Prior art keywords
- meptazinol
- salt
- transdermal administration
- transdermal
- administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75335705P | 2005-12-21 | 2005-12-21 | |
| US86211406P | 2006-10-19 | 2006-10-19 | |
| PCT/US2006/048783 WO2007075883A2 (en) | 2005-12-21 | 2006-12-21 | Transdermal delivery of meptazinol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1962817T3 true DK1962817T3 (da) | 2011-03-07 |
Family
ID=38198475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06848981.4T DK1962817T3 (da) | 2005-12-21 | 2006-12-21 | Transdermal tilførsel af et salt af meptazinol |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20070224253A1 (da) |
| EP (1) | EP1962817B1 (da) |
| AR (1) | AR058598A1 (da) |
| AT (1) | ATE488229T1 (da) |
| AU (1) | AU2006331596A1 (da) |
| CA (1) | CA2633369A1 (da) |
| DE (1) | DE602006018355D1 (da) |
| DK (1) | DK1962817T3 (da) |
| EA (1) | EA200801575A1 (da) |
| MX (1) | MX2008008050A (da) |
| PE (1) | PE20071163A1 (da) |
| PT (1) | PT1962817E (da) |
| TW (1) | TW200800223A (da) |
| UY (1) | UY30056A1 (da) |
| WO (1) | WO2007075883A2 (da) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090280064A1 (en) * | 2005-06-24 | 2009-11-12 | Rao Papineni | Transdermal delivery of optical, spect, multimodal, drug or biological cargo laden nanoparticle(s) in small animals or humans |
| WO2008079440A2 (en) | 2006-07-10 | 2008-07-03 | Medipacs, Inc. | Super elastic epoxy hydrogel |
| EP2227635A2 (en) | 2007-12-03 | 2010-09-15 | Medipacs, Inc. | Fluid metering device |
| US20090192095A1 (en) * | 2008-01-18 | 2009-07-30 | Shire Llc | Amino acid and peptide prodrugs of opioid analgesics with reduced gi side-effects |
| AU2009262967C1 (en) * | 2008-06-25 | 2015-12-24 | Fe3 Medical, Inc | Patches and methods for the transdermal delivery of a therapeutically effective amount of iron |
| US8190252B2 (en) * | 2009-02-12 | 2012-05-29 | Incube Labs, Llc | Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes |
| US9008765B2 (en) | 2009-02-12 | 2015-04-14 | Incube Labs, Llc | System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings |
| WO2010093472A2 (en) * | 2009-02-12 | 2010-08-19 | Incube Labs, Llc | Method and apparatus for oscillatory iontophoretic transdermal delivery of a therapeutic agent |
| US8961492B2 (en) | 2009-02-12 | 2015-02-24 | Incube Labs, Llc | System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation |
| US8821945B2 (en) * | 2009-04-25 | 2014-09-02 | Fe3 Medical, Inc. | Method for transdermal iontophoretic delivery of chelated agents |
| US8417330B2 (en) * | 2009-06-26 | 2013-04-09 | Incube Labs, Llc | Corrosion resistant electrodes for iontophoretic transdermal delivery devices and methods of use |
| WO2011032011A1 (en) | 2009-09-10 | 2011-03-17 | Medipacs, Inc. | Low profile actuator and improved method of caregiver controlled administration of therapeutics |
| WO2011044175A2 (en) * | 2009-10-06 | 2011-04-14 | Incube Labs, Llc | Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes |
| US8685038B2 (en) | 2009-12-07 | 2014-04-01 | Incube Labs, Llc | Iontophoretic apparatus and method for marking of the skin |
| US9500186B2 (en) | 2010-02-01 | 2016-11-22 | Medipacs, Inc. | High surface area polymer actuator with gas mitigating components |
| WO2011094814A1 (en) | 2010-02-05 | 2011-08-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
| WO2011100376A2 (en) | 2010-02-10 | 2011-08-18 | Incube Labs, Llc | Methods and architecture for power optimization of iontophoretic transdermal drug delivery |
| ES2829386T3 (es) | 2010-03-30 | 2021-05-31 | Phosphagenics Ltd | Parche de administración transdérmica |
| US8668675B2 (en) | 2010-11-03 | 2014-03-11 | Flugen, Inc. | Wearable drug delivery device having spring drive and sliding actuation mechanism |
| US9561243B2 (en) | 2011-03-15 | 2017-02-07 | Phosphagenics Limited | Composition comprising non-neutralised tocol phosphate and a vitamin A compound |
| CN103826696B (zh) | 2011-03-24 | 2017-03-22 | 因卡伯实验室有限责任公司 | 用于治疗剂的两阶段经皮离子电渗递送的系统及方法 |
| US8636696B2 (en) | 2011-06-10 | 2014-01-28 | Kimberly-Clark Worldwide, Inc. | Transdermal device containing microneedles |
| JP2015510956A (ja) | 2012-03-14 | 2015-04-13 | メディパックス インコーポレイテッド | 過剰反応性分子を含むスマートポリマー材料 |
| JP6522523B2 (ja) | 2013-02-28 | 2019-05-29 | ソレント・セラピューティクス・インコーポレイテッド | 経皮的薬物送達装置 |
| US9861801B2 (en) | 2013-02-28 | 2018-01-09 | Kimberly-Clark Worldwide, Inc. | Drug delivery device |
| US10376308B2 (en) | 2015-02-05 | 2019-08-13 | Axon Therapies, Inc. | Devices and methods for treatment of heart failure by splanchnic nerve ablation |
| CN108601732A (zh) | 2015-12-09 | 2018-09-28 | 磷肌酸有限公司 | 药物制剂 |
| AU2017301911B2 (en) | 2016-07-29 | 2022-07-28 | Axon Therapies, Inc. | Devices, systems, and methods for treatment of heart failure by splanchnic nerve ablation |
| WO2018112512A1 (en) | 2016-12-21 | 2018-06-28 | Phosphagenics Limited | Process |
| US10561461B2 (en) | 2017-12-17 | 2020-02-18 | Axon Therapies, Inc. | Methods and devices for endovascular ablation of a splanchnic nerve |
| JP7334167B2 (ja) | 2018-01-26 | 2023-08-28 | アクソン セラピーズ，インク． | 内臓神経の血管内アブレーションの為の方法及びデバイス |
| JP2022537018A (ja) | 2019-06-20 | 2022-08-23 | アクソン セラピーズ，インク． | 内臓神経の血管内アブレーションの方法及びデバイス |
| US11413090B2 (en) | 2020-01-17 | 2022-08-16 | Axon Therapies, Inc. | Methods and devices for endovascular ablation of a splanchnic nerve |
| CN113491675B (zh) * | 2021-07-01 | 2023-05-23 | 北京航空航天大学 | 一种预防瘢痕的微针创口贴及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1539277A (en) * | 1977-09-16 | 1979-01-31 | Wyeth John & Brother Ltd | Hexahydro-1h-azepines |
| IE55189B1 (en) * | 1982-07-08 | 1990-06-20 | Wyeth John & Brother Ltd | Pharmaceutical compositions |
| IE60941B1 (en) * | 1986-07-10 | 1994-09-07 | Elan Transdermal Ltd | Transdermal drug delivery device |
| US6916486B2 (en) * | 1996-02-19 | 2005-07-12 | Acrux Dds Pty Ltd | Transdermal delivery of analgesics |
| AU4972599A (en) * | 1998-07-07 | 2000-01-24 | Transdermal Technologies, Inc. | Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof |
| US6716449B2 (en) * | 2000-02-08 | 2004-04-06 | Euro-Celtique S.A. | Controlled-release compositions containing opioid agonist and antagonist |
| DE10059415A1 (de) * | 2000-11-30 | 2002-06-06 | Gruenenthal Gmbh | Verwendung von schwachen Opioiden und gemischten Opioidagonisten/-antagonisten zur Therapie der Harninkontinenz |
| DK1530469T3 (da) * | 2002-08-20 | 2009-05-04 | Euro Celtique Sa | Transdermal dosisform omfattende et aktivt middel og et salt og fri baseform af en antagonist |
| UA82880C2 (en) * | 2003-04-30 | 2008-05-26 | Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer |
-
2006
- 2006-12-20 TW TW095147948A patent/TW200800223A/zh unknown
- 2006-12-21 UY UY30056A patent/UY30056A1/es not_active Application Discontinuation
- 2006-12-21 WO PCT/US2006/048783 patent/WO2007075883A2/en active Application Filing
- 2006-12-21 PE PE2006001676A patent/PE20071163A1/es not_active Application Discontinuation
- 2006-12-21 PT PT06848981T patent/PT1962817E/pt unknown
- 2006-12-21 AU AU2006331596A patent/AU2006331596A1/en not_active Abandoned
- 2006-12-21 DE DE602006018355T patent/DE602006018355D1/de active Active
- 2006-12-21 AR ARP060105700A patent/AR058598A1/es unknown
- 2006-12-21 DK DK06848981.4T patent/DK1962817T3/da active
- 2006-12-21 US US11/614,165 patent/US20070224253A1/en not_active Abandoned
- 2006-12-21 EA EA200801575A patent/EA200801575A1/ru unknown
- 2006-12-21 MX MX2008008050A patent/MX2008008050A/es unknown
- 2006-12-21 CA CA002633369A patent/CA2633369A1/en not_active Abandoned
- 2006-12-21 AT AT06848981T patent/ATE488229T1/de active
- 2006-12-21 EP EP06848981A patent/EP1962817B1/en not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| AR058598A1 (es) | 2008-02-13 |
| WO2007075883A3 (en) | 2008-01-17 |
| AU2006331596A1 (en) | 2007-07-05 |
| DE602006018355D1 (de) | 2010-12-30 |
| EP1962817A2 (en) | 2008-09-03 |
| UY30056A1 (es) | 2007-06-29 |
| MX2008008050A (es) | 2009-04-06 |
| TW200800223A (en) | 2008-01-01 |
| WO2007075883A9 (en) | 2007-08-23 |
| ATE488229T1 (de) | 2010-12-15 |
| US20070224253A1 (en) | 2007-09-27 |
| CA2633369A1 (en) | 2007-07-05 |
| EA200801575A1 (ru) | 2008-12-30 |
| EP1962817B1 (en) | 2010-11-17 |
| WO2007075883A2 (en) | 2007-07-05 |
| PE20071163A1 (es) | 2007-11-30 |
| PT1962817E (pt) | 2010-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1962817T3 (da) | Transdermal tilførsel af et salt af meptazinol | |
| NO2022057I1 (no) | Capmatinib or a pharmaceutically acceptable salt thereof | |
| NL301106I1 (nl) | Cenobamaat of een farmaceutisch aanvaardbaar zout daarvan | |
| NL350108I2 (nl) | Isofetamid of een zout daarvan | |
| NL301003I2 (nl) | Sotagliflozin of een farmaceutisch aanvaardbaar zout daarvan | |
| NL300993I2 (nl) | Apalutamide of een farmaceutisch aanvaardbaar zout daarvan | |
| NL300865I2 (nl) | Eluxadoline of een farmaceutisch aanvaardbaar zout ervan | |
| NL300885I2 (nl) | Irinotecansucrosofaatzout | |
| CY2014012I1 (el) | Χορηγηση αναστολεων διπεπτιδυλοπεπτιδασης | |
| DK1802579T3 (da) | Derivater af 3-arylaminopyridin | |
| DK1745052T3 (da) | HIV-intergrase-inhibitorer: cykliske pyrimidinonforbindelser | |
| DK2124933T3 (da) | Tosylatsalt af en terapeutisk forbindelse og farmaceutiske sammensætninger deraf | |
| DK2081551T3 (da) | Dannelse af en tørret rekonstitueret vesikel til farmaceutisk anvendelse | |
| DK2058020T3 (da) | Indretning til indgivelse af lægemiddel | |
| DK1940467T3 (da) | Lægemiddelsammensætning med langvarig frigivelse | |
| DK2041139T3 (da) | Farmaceutiske forbindelser | |
| DK2089364T3 (da) | Pyridinonforbindelser | |
| DK1720866T3 (da) | Fremgangsmåde | |
| DK1753764T3 (da) | Pyrrolopyridin-derivater | |
| DK1942967T3 (da) | Fremgangsmåde til dosering af medikamenter | |
| ATE402154T1 (de) | Monohydrochloridsalz von 1-ä3-ä3-(4- chlorphenyl)propoxyüpropylüpiperidin | |
| DK1763520T3 (da) | Anvendelse af trisubstituerede benzopyranoner | |
| DE502005005664D1 (de) | Chronograph | |
| BRPI0716742A2 (pt) | Lactamas terapêuticas | |
| NO20043305D0 (no) | Preparation of lodixanol |